Volume 21, Number 6—June 2015
Salmonella enterica Serotype Enteritidis in French Polynesia, South Pacific, 2008–2013
|Period of isolation||Origin of sample||Sample type (no.)||No. isolates||Antimicrobial resistance profile (no.)||PFGE types (no.)||Phage types (no.)||CRISPR types, allele1-allele2 (no.)||MLVA type (no.)†|
|2011 Oct 25||Restaurant||Tuna dish with raw eggs||1||Susceptible||JEGX01.0004||A14-B20||2-10-8-6-2|
|2011 Nov–Jan 2012||Farm A||Egg (5), feces (1)||6||Susceptible (6)||JEGX01.0004 (5), XEN-033 (1)||8 (2), 23 (1)||A14-B21 (5), A14-B20 (1)||2-10-8-5-2 (4), 2-11-8-5-2 (1), 2-10-8-6-2 (1)|
|2011 Jan–2012 Dec||Farm B||Feces (5), dust (3)||8||Susceptible (8)||JEGX01.0004 (8)||8 (3), 13a (2)||A14-B21 (8)||2-10-8-5-2 (3), 2-11-8-5-2 (1), 2-9-8-5-2 (4)|
||Imported chicken product
|*The spacer content of each CRISPR-type is described in online Technical Appendix 1 (http://wwwnc.cdc.gov/EID/article/21/6/14-1103-Techapp1.xls). CRISPR, clustered regularly interspaced short palindromic repeats; MLVA, multilocus variable-number tandem-repeat analysis; NP, not performed; PFGE, pulsed-field gel electrophoresis. †SENTR7-SENTR5-SENTR6-SENTR4-SE3.|
1Current affiliation: Cellule de l’Institut de Veille Sanitaire en Région Antilles Guyane, Fort de France, Martinique, France.
Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.